Human papillomavirus genotype and oropharynx cancer survival in the United States of America
- 1 December 2015
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 51 (18) , 2759-2767
Abstract
No abstract availableKeywords
Funding Information
- Centres for Disease Control and Prevention (5U58DP000810-5, 5U58DP000844-5, 5U58DP000812-5, 5U58DP000769-5)
- National Institutes of Health (N01-PC-35143, N01-PC-35137)
This publication has 39 references indexed in Scilit:
- Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK populationBMC Cancer, 2013
- Performance of Commercial Reverse Line Blot Assays for Human Papillomavirus GenotypingJournal of Clinical Microbiology, 2012
- HPV Genotypes in High Grade Cervical Lesions and Invasive Cervical Carcinoma as Detected by Two Commercial DNA Assays, North Carolina, 2001–2006PLOS ONE, 2012
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- Efficient DNA Extraction for HPV Genotyping in Formalin-Fixed, Paraffin-Embedded TissuesThe Journal of Molecular Diagnostics, 2011
- Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III TrialJournal of Clinical Oncology, 2010
- Human papillomavirus‐active head and neck cancer and ethnic health disparitiesThe Laryngoscope, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancerInfectious Agents and Cancer, 2010
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008